Arcutis Biotherapeutics, Inc. (ARQT) vs Enliven Therapeutics, Inc. (ELVN)
Arcutis Biotherapeutics, Inc. and Enliven Therapeutics, Inc. are both Biotechnology companies. Arcutis Biotherapeutics, Inc. and Enliven Therapeutics, Inc. are of similar size ($3.4B and $3.3B). Enliven Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Arcutis Biotherapeutics, Inc. trades at 122×. Arcutis Biotherapeutics, Inc. has the higher net margin (6.15% vs 0.00%) and the higher return on invested capital (23.6% vs 0.00%). Across the 14 metrics below, Arcutis Biotherapeutics, Inc. leads on 10 and Enliven Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | ARQT | ELVN | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.14% | 0.00% | 65.16% |
| Operating margin | 7.38% | 0.00% | 0.00% |
| Net margin | 6.15% | 0.00% | 0.00% |
| Free cash flow margin | 8.42% | 0.00% | 0.00% |
| Return on equity | 15.86% | (15.31%) | (57.72%) |
| Return on assets | 6.78% | (14.98%) | (49.22%) |
| Return on invested capital | 23.62% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack